Alex Nemiroff

General Counsel at PRAXIS PRECISION MEDICINES, INC.

Net worth: 9 M $ as of 2026-05-30

47 year

Consumer Services

Health Technology

Profile

Alex Nemiroff is the founder of RogCon, Inc., established in 2015, holding the title of Chief Executive Officer.
Mr. Nemiroff is the founder of RogCon U.R., Inc., established in 2015, holding the title of Chief Executive Officer.
Mr. Nemiroff currently works at Praxis Precision Medicines, Inc. as Secretary & General Counsel since 2020.
Mr. Nemiroff completed undergraduate education at Stephen M.
Ross School of Business and graduate education at Northwestern University School of Law.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
PRAXIS PRECISION MEDICINES, INC. 0.09%	2026-05-13	26,011 ( 0.09% )	9 M $	2026-05-30

Alex Nemiroff active positions

Companies	Position	Start
PRAXIS PRECISION MEDICINES, INC.	General Counsel	2019-12-31
RogCon, Inc. RogCon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focused on drug research, discovery and development	Chief Executive Officer	2015-10-31
RogCon U.R., Inc.	Chief Executive Officer	2015-10-31

All active positions of Alex Nemiroff

Training of Alex Nemiroff

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alex Nemiroff's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Stephen M. Ross School of Business Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Northwestern University School of Law Northwestern University School of Law Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Praxis Precision Medicines, Inc. Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders	Health Technology
RogCon, Inc. RogCon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focused on drug research, discovery and development	Health Technology
RogCon U.R., Inc.